Eastgate Biotech (OTCMKTS:ETBI) Shares Pass Above Fifty Day Moving Average – Here’s What Happened

Eastgate Biotech Corp. (OTCMKTS:ETBI)’s share price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0001. Eastgate Biotech shares last traded at $0.0001, with a volume of 25,000 shares changing hands.

Eastgate Biotech Price Performance

Eastgate Biotech Company Profile

Eastgate Biotech, Inc is a developmental-stage biotechnology company focused on the research and development of advanced lipid nanoparticle (LNP) drug delivery systems. The company’s proprietary platform is designed to facilitate the targeted transport of nucleic acid therapies, including mRNA and siRNA, to specific tissues in order to maximize therapeutic efficacy and minimize off-target effects. By harnessing the versatility of its LNP technology, Eastgate Biotech aims to enable the next generation of precision medicines for a variety of genetic and degenerative conditions.

Leveraging its LNP platform, Eastgate Biotech is assembling a pipeline of preclinical therapeutic candidates, with particular emphasis on ocular and neuromuscular applications.